A tax overhaul, a KOSDAQ delisting wave, and a Chinese insulin push into the U.S. — Korea's top stories today.
Korea's 2026 tax reform sharply raises comprehensive real estate tax rates for non-resident and multiple-home owners, with new brackets starting at 2.2 billion won ($1.54 million) taking effect for 2027 tax bills. Meanwhile, tighter KOSDAQ delisting standards are now flagging roughly one in six of the market's 1,830 listed companies. Elsewhere, a Chinese generic drugmaker cleared the way to enter the U.S. insulin market, challenging the three companies that have long controlled about 85% of global supply.
Sources:
Comprehensive Real Estate Tax Set to Rise Sharply for Non-Resident Owners Above 2.2 Billion Won — Seoul Economic Daily, Aug 4, 2026
One in Six KOSDAQ Companies at Delisting Risk a Month After Tighter Rules — Seoul Economic Daily, Aug 4, 2026
Chinese Generic Drugmaker Pushes Into the U.S. Insulin Market — Seoul Economic Daily, Aug 4, 2026
About AI PRISM:
AI PRISM is Seoul Economic Daily's WAN-IFRA award-winning newsroom AI series, delivering Korean economic news adapted for global audiences. Episodes are produced with AI assistance and reviewed by a human editor.
Tags:
#KoreaTax #RealEstateTax #KOSDAQ #Delisting #Insulin #KOSPI #AIPRISM #SeoulEconomicDaily #WANIFRA
